Insider buying last 90 days
No open-market insider purchases were filed for HTFL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
Heartflow closed at $49.92 on 28 September 2026, +1.5% on the day. The price sits above both the 50-day ($40.09) and 200-day ($31.39) moving averages, inside a 52-week range of $20.13 to $52.22. The GekkoIndex reads 52.4, in the Neutral zone, up 3.4 points over five sessions. Gekko Fair Value is $42.45, so the price is 17.6% above it.
The next earnings report is due on 11 November 2026, 43 days away. Over the last 5 reports the company beat the earnings estimate 3 times, with an average move of 17.1% across the report.
10 firms rate the stock: 8 buy, 2 hold and 0 sell, with a consensus target of $46.00. A typical daily move is about 5%, and a typical 20-day move about 12.4%. On the swing-trade checklist, 2 items read supportive and 1 reads as a headwind (fair value).
Generated Sep 29, 2026 from the data above.
Heartflow scores 2 supportive, 1 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed1 headwind
Above 50 and 200-day
Close $49.92 is above the 50-day ($40.09) and 200-day ($31.39) averages, and the 50-day is above the 200-day.
See the chart52.4, Neutral
Reading 52.4 is in the Neutral zone.
See the GekkoIndex17.6% above
Price is 17.6% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 43 days
Next report Nov 11, 2026, 43 days away — outside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Heartflow closed at $49.92 on Sep 28, 2026, +47.2% over the past year, inside a 52-week range of $20.13 to $52.22.
Use the left and right arrow keys to read daily values.
Put HTFL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Heartflow makes technology used to diagnose and manage coronary artery disease without surgery. Its core offering, the Heartflow Platform, uses artificial intelligence and computational fluid dynamics to build a three-dimensional digital model of a patient's heart from a single coronary CT angiography scan. The platform is best known for turning that one scan into detailed readings of blood flow, arterial narrowing, and plaque volume and makeup, addressing gaps left by conventional non-invasive imaging.
The company positions its platform as a tool for clinicians involved in heart disease diagnosis and ongoing patient care, built around the CCTA scan as its data source rather than requiring additional invasive procedures.
Heartflow was founded in 2007 and is headquartered in Mountain View, California. Its shares are listed on the NASDAQ under the ticker HTFL.
Heartflow’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 52.4, in the Neutral zone, up 3.4 points over five sessions.
Up 3.4 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 9 | Too few readings yet | |||
| Accumulation | 89 | −0.3% | +16.3% | ||
| Neutral (current zone) | 156 | +2.7% | +2.2% | ||
| Distribution | 19 | −5.6% | −7.6% | ||
| Selling | 7 | Too few readings yet | |||
Average HTFL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Heartflow trades 17.6% above Gekko Fair Value of $42.45, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Heartflow shares are worth, recalculated every trading day.
$42.45
Gekko Fair Value, Sep 29, 2026
17.6% Overvalued
No open-market insider purchases were filed for Heartflow, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for HTFL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in HTFL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Heartflow has been buying back its own shares.
From company filings.
3of the funds Gekko tracks hold HTFL.
Heartflow reports on Nov 11, 2026 (43 days away), and beat the EPS estimate in 3 of its last 5 reports.
Nov 11, 2026
43 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 13, 2026 | −$1.46 est −$0.22 | $64.08M est $56.64M | +41.0% |
| May 14, 2026 | −$0.16 est −$0.17 | $52.59M est $49.71M | −9.2% |
| Mar 18, 2026 | −$0.12 est −$0.15 | $49.13M est $46.58M | +15.0% |
| Sep 19, 2025 | −$0.06 est −$0.21 | $43.41M est $43.20M | −3.2% |
| Jul 17, 2025 | −$0.46 est −$0.21 | $37.20M est $43.20M | — |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Heartflow is $46.00, −7.9% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 22 | Canaccord Genuity | $56 | +12.2% |
| Sep 11 | William Blair | — | — |
| Sep 9 | UBS | $55 | +10.2% |
| Aug 21 | William Blair | — | — |
| Aug 17 | Morgan Stanley | $40 | −19.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Heartflow’s market cap is $4.31B and revenue of $212.1M over the last twelve months.
Coverage of Heartflow this week reads neutral: 1 positive, 2 neutral and 1 negative headlines.
Heartflow’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 17.3% above |
| PLTRPalantir Technologies | Neutral | 15.7% above |
| ORCLOracle | Accumulation | 25.9% below |
| PANWPalo Alto Networks | Neutral | 16.1% above |
| CRWDCrowdStrike | Neutral | 27.2% above |
| CRMSalesforce | Neutral | 5.9% below |
A peer links to its own page where one exists.
Heartflow’s market cap is $4.31B at the Sep 28, 2026 close of $49.92, with 86.95M shares outstanding.
The consensus analyst 12-month price target for Heartflow is $46.00, −7.9% from the last close. Of the 10 firms that rated the stock in the last 90 days, 8 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Heartflow is overvalued: the Sep 28, 2026 close of $49.92 is 17.6% above Gekko Fair Value of $42.45. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Heartflow is expected to report on Nov 11, 2026 (43 days away). Analysts expect earnings of −$0.10 per share on revenue of $65.26M. Heartflow beat the earnings estimate in 3 of its last 5 reports, moving 17.1% on average across the report.
Heartflow’s 52-week high is $52.22 and its 52-week low is $20.13; it closed at $49.92 on Sep 28, 2026, +47.2% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and earnings risk), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.